Clinical efficacy and safety of subtotal resection of adenomyotic lesions based on the Kishi classification: a retrospective case series study - Scorecard - MDSpire
Advertisement
Clinical efficacy and safety of subtotal resection of adenomyotic lesions based on the Kishi classification: a retrospective case series study
Clinical Scorecard: Efficacy and Safety of Subtotal Resection for Adenomyotic Lesions According to Kishi Classification: A Retrospective Case Series Analysis
At a Glance
Category
Detail
Condition
Severe Adenomyosis
Key Mechanisms
Subtotal resection of adenomyotic lesions combined with sequential LNG-IUS and GnRH-a therapy.
Target Population
Patients with severe adenomyosis desiring uterine preservation and not seeking future fertility.
Care Setting
Department of Gynecology, Changzhou Second People’s Hospital Affiliated to Nanjing Medical University.
Key Highlights
Significant improvements in dysmenorrhea severity, menstrual blood loss, hemoglobin levels, CA125 levels, and uterine volume post-surgery.
No serious adverse events reported during the study.
All patients successfully underwent surgery with a follow-up period of 12 months.
Only one case of mild CA125 elevation and one case of intrauterine device displacement noted.
No disease progression observed in any patient.
Guideline-Based Recommendations
Diagnosis
Utilize Kishi classification based on MRI for guiding clinical treatment.
Management
Perform subtotal resection of adenomyotic lesions followed by LNG-IUS and GnRH-a therapy.
